Quantcast

Latest Coronary artery bypass surgery Stories

2010-11-16 09:00:00

CHICAGO, Nov. 16, 2010 /PRNewswire-FirstCall/ -- New results from an observational substudy from TRITON-TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient®/Effient® (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix® (clopidogrel) (2.3 percent versus 8.7...

2010-11-15 08:16:11

(Ivanhoe Newswire) "“ Drinking two to three drinks daily among male coronary artery bypass patients was associated with 25 percent fewer subsequent cardiovascular procedures, heart attacks, strokes, and death compared to non-drinkers. The study also showed bypass patients with left ventricular dysfunction who were moderate to heavy drinkers were twice as likely to have subsequent cardiovascular deaths compared to non-drinkers. "The benefit of light amounts of alcohol consumption has...

2010-10-27 07:00:00

REDWOOD CITY, Calif, Oct. 27/PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that its C-Port® Flex-A® Anastomosis System and its PAS-Port® Proximal Anastomosis System will be featured in several demonstration and wet lab presentations at the Advances in Robotic and Hybrid Coronary Revascularization conference, a meeting jointly developed by the International College of Robotic Surgery and Saint Joseph's Hospital in Atlanta,...

2010-10-25 07:00:00

REDWOOD CITY, Calif., Oct. 25 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced the publication of a 5-year study demonstrating the safety and efficacy of its PAS-Port® Proximal Anastomosis System. The study, published in the November 2010 issue of the Annals of Thoracic Surgery, evaluated the frequency of major adverse events five years after undergoing coronary artery bypass graft (CABG) surgery using the PAS-Port system and patency (openness) of the grafted...

2010-10-22 18:54:52

A toxin found in the venom of the Central American bark scorpion (Centruroides margaritatus) could hold the key to reducing heart bypass failures, according to research from the University of Leeds. The study, published online in Cardiovascular Research, reports that one of the scorpion's toxins, margatoxin, is at least 100 times more potent at preventing neointimal hyperplasia - the most comon cause of bypass graft failure - than any other known compound. Neointimal hyperplasia is the blood...

2010-10-12 18:55:02

A study that includes data on more than 100,000 patients who underwent coronary artery bypass graft surgery finds that there is wide variability among hospitals in the U.S. on the use of blood transfusions, without a large difference in the rate of death, suggesting that many transfusions may be unnecessary, according to a study in the October 13 issue of JAMA. Another study in this issue of JAMA examines the effect of a restrictive transfusion strategy on outcomes after cardiac surgery....

2010-10-12 18:52:56

Transfusion rates for blood products used in a common heart surgery range from no patients to nearly all patients, and vary by hospital, according to findings from a group of researchers from Duke University Medical Center. The study, which looked at data from 102,470 patients in 798 hospitals, examined the variation in transfusion rates for red blood cells (RBCs), plasma and platelets, but the team didn't reach conclusions about how well patients fared if they did or didn't get a...

2010-10-04 07:00:00

WAYNE, N.J., Oct. 4 /PRNewswire/ -- MAQUET Cardiovascular today announced the availability of a "Golden Rules" whitepaper documenting endoscopic vessel harvesting (EVH) best practices. EVH is a minimally invasive technique widely used during coronary artery bypass graft (CABG) surgery to remove a vessel from the leg or arm of a patient that is then used as conduit by bypassing blockages. The paper highlights the value EVH provides patients, and consolidates the vast scientific...

2010-09-22 07:00:00

WAYNE, N.J., Sept. 22 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with...

2010-09-14 07:00:00

REDWOOD CITY, Calif. and HOUSTON, Sept. 14 /PRNewswire/ -- Nationally-renowned cardiovascular and thoracic surgeon Mahesh Ramchandani, M.D. of the Methodist DeBakey Heart & Vascular Center in Houston is innovating minimally-invasive cardiac surgery using Cardica, Inc.'s (Nasdaq: CRDC) C-Port® Distal Anastomosis and PAS-Port® Proximal Anastomosis Systems. Dr. Ramchandani offers patients an alternative to traditional "open chest" bypass procedures...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.